Q1 2019 Holdings
Filed 2019-05-15 | 82 holdings | $228.6M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2019-05-20) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $127.2M | 1,019,061 | 55.6% |
| Align Technology Inc(ALGN) | COM | 016255101 | $40.7M | 143,200 | 17.8% |
| Biogen Inc(BIIB) | COM | 09062X103 | $39.1M | 165,300 | 17.1% |
| Atricure Inc(ATRC) | COM | 04963C209 | $8.7M | 325,000 | 3.8% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $5.3M | 40,400 | 2.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $2.2M | 150,955 | 1.0% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $2.1M | 323,265 | 0.9% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $267.5K | 10,970,518 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $266.8K | 19,616,062 | 0.1% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $182.0K | 10,359,666 | 0.1% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $178.3K | 4,485,417 | 0.1% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $113.3K | 4,563,929 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR)A | COM | 014339105 | $112.5K | 8,244,896 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $110.0K | 2,831,507 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $106.7K | 2,735,267 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $95.3K | 7,694,020 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $94.3K | 3,036,603 | 0.0% |
| Wright MED Group N V | ORD SHS | N96617118 | $90.4K | 2,874,100 | 0.0% |
| Inflarx NV(IFRX) | COM | N44821101 | $82.5K | 2,182,638 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $81.4K | 1,420,342 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $78.0K | 1,307,522 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $76.3K | 1,599,700 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $76.2K | 1,222,405 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $74.3K | 1,834,410 | 0.0% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $68.0K | 11,320 | 0.0% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $56.7K | 582,687 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $54.4K | 855,932 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $50.7K | 176,700 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $50.5K | 535,700 | 0.0% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $49.3K | 3,147,000 | 0.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $47.5K | 323,170 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $39.1K | 2,943,765 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $38.5K | 2,051,089 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $38.5K | 269,480 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $37.8K | 1,628,653 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $36.3K | 496,918 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $35.4K | 13,063,767 | 0.0% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $34.5K | 2,001,467 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $33.7K | 2,212,456 | 0.0% |
| Array Biopharma Inc | NOTE 2.625%12/0 | 04269XAB1 | $33.3K | $19,000,000 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $32.9K | 132,890 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $32.2K | 1,374,175 | 0.0% |
| Gritstone Oncology Inc(2JQ) | COM | 39868T105 | $31.3K | 2,353,735 | 0.0% |
| Xeris Pharmaceuticals Inc | COM | 98422L107 | $30.1K | 3,000,641 | 0.0% |
| Tcr2 Therapeutics Inc | COM | 87808K106 | $28.7K | 1,807,256 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $25.1K | 2,018,247 | 0.0% |
| Teladoc Health Inc(TDOC) | COM | 87918A105 | $24.5K | 439,900 | 0.0% |
| Alder Biopharmaceuticals Inc | NOTE 2.500% 2/0 | 014339AA3 | $23.9K | $25,000,000 | 0.0% |
| Morphosys AG | SPONSORED ADS | 617760202 | $20.3K | 893,800 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $20.0K | 851,900 | 0.0% |